Vertex (VRTX) Reiterated at Overweight by Cantor Fitzgerald; Crinetics Acquisition Announced
July 7, 2026 7:16 AM
Cantor Fitzgerald analyst Carter Gould reiterated an Overweight rating and $590.00 price target on Vertex (NASDAQ: VRTX).The analyst commented, "Vertex ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
